Arcadia Biosciences Inc Revenue Growth Rates (RKDA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Arcadia Biosciences Inc   (NASDAQ: RKDA)
    Sector • Energy    Industry • Oil And Gas Production
   Industry • Oil And Gas Production
   Sector • Energy
 

RKDA's Revenue Growth by Quarter and Year

Arcadia Biosciences Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RKDA Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 1.44
1st Quarter March 1.10
FY 2.54

RKDAs Annual Revenue
Arcadia Biosciences Inc 's Revenue in the fiscal year 2025 $ 4.86 millions
Arcadia Biosciences Inc 's Revenue in the fiscal year 2024 $ 5.05 millions
Arcadia Biosciences Inc 's Revenue in the fiscal year 2023 $ 5.33 millions
Arcadia Biosciences Inc 's Revenue in the fiscal year 2022 $ 9.96 millions
Arcadia Biosciences Inc 's Revenue in the fiscal year 2021 $ 6.78 millions




RKDA Revenue second quarter 2026 Y/Y Growth Comment
Arcadia Biosciences Inc reported decrease in Revenue in the second quarter 2026 by -1.16% to $ 1.44 millions, from the same quarter in 2025.
The decrease in the second quarter 2026 Arcadia Biosciences Inc 's Revenue compares unfavorably to the Company's average Revenue jump of 59.46%.

Looking into second quarter 2026 results within Oil And Gas Production industry 60 other companies have achieved higher Revenue growth. While Arcadia Biosciences Inc ' s Revenue decline of -1.16% ranks overall at the positon no. 2892 in the second quarter 2026.


RKDA Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - -5.26 % 13.1 % -16 %
3rd Quarter September - -15.58 % -3.75 % -14.89 %
2nd Quarter June -1.16 % 11.45 % -5.76 % -63.99 %
1st Quarter March -8.33 % -4.76 % -16.56 % -53.11 %
FY   - -3.95 % -5.24 % -

Financial Statements
Arcadia Biosciences Inc 's second quarter 2026 Revenue $ 1.44 millions RKDA's Income Statement
Arcadia Biosciences Inc 's second quarter 2025 Revenue $ 1.46 millions Quarterly RKDA's Income Statement


RKDA Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - -30.77 % -38.31 % -47.5 %
3rd Quarter September - -10.96 % 17.56 % 15.11 %
2nd Quarter June 31.18 % 21.67 % 3.97 % -7.95 %
1st Quarter March 22.22 % 26.32 % 50 % 51 %
FY (Year on Year)   - -3.95 % -5.24 % -


Back to RKDA Growth rate Comparisons >> Back to RKDA Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Oil And Gas Production Industry #61
Energy Sector #89
Overall #2892

Revenue Y/Y Growth Statistics
High Average Low
1613.94 % 59.46 % -78.98 %
(Sep 30 2021)   (Dec 31 2018)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Oil And Gas Production Industry #61
Energy Sector #89
Overall #2892
Revenue Y/Y Growth Statistics
High Average Low
1613.94 % 59.46 % -78.98 %
(Sep 30 2021)   (Dec 31 2018)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Arcadia Biosciences Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
2170.7 % 52.8 % -88.39 %
(Dec 31 2020)  


RKDA's II. Quarter Q/Q Revenue Comment
Arcadia Biosciences Inc achieved in the II. Quarter 2026 below company average Revenue jump of 31.18% quarter on quarter, to $ 1.44 millions.

Although the II. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the II. Quarter surge, eclipses the 21.67% growth in the II. Quarter a year ago

Within Oil And Gas Production industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Arcadia Biosciences Inc 's Revenue growth quarter on quarter, overall rank is 366.


Revenue Q/Q Growth Company Ranking
Within: No.
Oil And Gas Production Industry #19
Energy Sector #20
Overall #366
Revenue Q/Q Growth Company Ranking
Within: No.
Oil And Gas Production Industry #19
Energy Sector #20
Overall #366
Revenue Q/Q Growth Statistics
High Average Low
2170.7 % 52.8 % -88.39 %
(Dec 31 2020)  


RKDA's II. Quarter Q/Q Revenue Comment
Arcadia Biosciences Inc achieved in the II. Quarter 2026 below company average Revenue jump of 31.18% quarter on quarter, to $ 1.44 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 21.67% in the II. Quarter a year ago.

Within Oil And Gas Production industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Arcadia Biosciences Inc 's Revenue growth quarter on quarter, overall rank is 366.


Arcadia Biosciences Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 4.75 $ 4.76 $ 4.86 $ 4.90 $ 5.14
Y / Y Revenue Growth (TTM) -7.65 % -4.65 % -3.71 % -0.59 % 2.92 %
Year on Year Revenue Growth Overall Ranking # 2296 # 2489 # 2553 # 2874 # 2482
Seqeuential Revenue Change (TTM) -0.25 % -2.06 % -0.94 % -4.57 % 2.99 %
Seq. Revenue Growth (TTM) Overall Ranking # 2291 # 2433 # 1954 # 2277 # 1965


Cumulative Revenue growth Comment
Arcadia Biosciences Inc 's cumulative 12 months Revenue continue to decline, but on the faster rate at -7.65% year on year, at Jun 30 2026 compare to the -4.65% decrease at Mar 31 2026. If the Arcadia Biosciences Inc 's fiscal year would end at Jun 30 2026, annual Revenue would be $5 millions.

In the Energy sector 49 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2296, from total ranking in previous quarter at 2489.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Oil And Gas Production Industry # 39
Energy Sector # 50
Overall # 2296

Revenue TTM Y/Y Growth Statistics
High Average Low
789.32 %
 42.98 %
-63.64 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 39
Sector # 50
S&P 500 # 2291
Cumulative Revenue growth Comment
Arcadia Biosciences Inc 's cumulative 12 months Revenue continue to decline, but on the faster rate at -7.65% year on year, at Jun 30 2026 compare to the -4.65% decrease at Mar 31 2026. If the Arcadia Biosciences Inc 's fiscal year would end at Jun 30 2026, annual Revenue would be $5 millions.

In the Energy sector 49 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2296, from total ranking in previous quarter at 2489.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Oil And Gas Production Industry # 39
Energy Sector # 50
Overall # 2296

Revenue TTM Y/Y Growth Statistics
High Average Low
789.32 %
42.98 %
-63.64 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 39
Sector # 50
S&P 500 # 2291




Other Revenue Growth
Oil And Gas Production Industry Revenue Growth Trends and Statistics
Energy Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RKDA's Revenue Growth Ratio versus Oil And Gas Production Industry, Energy Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decline for the quarter ending Jun 30 2026 within Energy SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Helmerich and Payne inc -0.58%$ -0.583 millions
Profrac Holding Corp -0.76%$ -0.757 millions
Arcadia Biosciences Inc -0.82%$ -0.825 millions
Nabors Industries Ltd-2.16%$ -2.161 millions
Transocean ltd -2.23%$ -2.227 millions
Range Resources Corporation-2.65%$ -2.651 millions
Hess Midstream Lp-3.67%$ -3.670 millions
Nine Energy Service Inc -3.70%$ -3.698 millions
Core Laboratories Inc -4.26%$ -4.264 millions
Ramaco Resources Inc -5.33%$ -5.335 millions
Omega Flex Inc -5.37%$ -5.369 millions
Propetro Holding Corp -6.24%$ -6.236 millions
Black Stone Minerals L p -6.60%$ -6.597 millions
Team Inc -7.45%$ -7.451 millions
Alpha Metallurgical Resources Inc -10.43%$ -10.434 millions
Noble Corporation Plc-15.20%$ -15.196 millions
Expand Energy Corporation-19.78%$ -19.783 millions
Comstock Resources Inc -24.88%$ -24.875 millions
Gulfport Energy Corporation-27.79%$ -27.789 millions
Eqt Corporation-29.24%$ -29.236 millions
Cnx Resources Corporation-35.74%$ -35.737 millions
Eagle Rock Energy Partners L P-41.75%$ -41.748 millions
New Era Energy and Digital Inc -82.55%$ -82.546 millions
Apa Corporation-94.63%$ -94.628 millions


About Arcadia Biosciences Inc Revenue Growth Rates (RKDA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Arcadia Biosciences Inc (CIK 1469443).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-349205
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Arcadia Biosciences Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.